Ligo AI

Ligo AI (Ligo Biosciences) is a biotech startup born out of the University of Oxford, focused on using generative artificial intelligence (AI) to design and develop enzymes (biocatalysts) for industrial production.

It targets the pain points of traditional chemical manufacturing, which relies on hazardous materials, consumes a lot of energy, and emits significant pollution, as well as the limitations of natural enzymes in catalyzing many industrial reactions and the long time required for conventional enzyme development (years).

Its technology is built on deep learning models that learn catalytic principles to generate new enzyme designs, followed by wet-lab synthesis and functional validation, enabling a closed loop between computation and experimentation.

Applications include pharmaceutical manufacturing, fine chemical production, food toxin degradation, environmental pollutant breakdown, and other potential industrial catalysis processes.

The main advantages are drastically shortening enzyme design and development time—from years to days—and creating custom enzymes that do not exist in nature, making chemical manufacturing cheaper and greener.

The company is at the seed stage, having completed financing led by Y Combinator, secured the first LOIs from potential customers, and is beginning contract R&D.